| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
5
5
4
4
1
|
|
Zacks Investment Research
5
(Strong Sell)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
B+
(Buy)
|
Fund Holdings
The fund's portfolio is fairly concentrated.
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 3.76 | 3.76 |
| Stocks | 87.13 | 87.13 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 9.11 | 9.11 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 05.31.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Affiliated Managers Group Inc | AMG | 25.29 | 6.41 |
| Core Laboratories N.V. | CLB | 26.03 | 5.9 |
| j2 Global Inc | JCOM | 35.07 | 5.43 |
| NeuStar, Inc. | NSR | 15.67 | 5.12 |
| DineEquity Inc | DIN | 9.58 | 5.1 |
| MSCI, Inc. | MSCI | 13.49 | 5.06 |
| Graco Incorporated | GGG | 27.05 | 5.0 |
| SBA Communications Corp | SBAC | 6.03 | 4.85 |
| Sally Beauty Holdings Inc | SBH | 29.19 | 4.79 |
| VeriSign, Inc. | VRSN | 20.3 | 4.59 |
